- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05496985
Chinese Validation of the Simplified Evaluation of CONsciousness Disorders(SECONDs)
August 9, 2022 updated by: Haibo Di, Hangzhou Normal University
The aim of this study was to translate the SECONDs from French into Chinese and assess the validity and reliability of the Chinese version of the SECONDs .
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
To promote accurate assessments of DoC patients and the development of clinical research on DoC in China, we here propose and validate a version of the SECONDs translated into Mandarin Chinese.
Hence, this study aims to assess the concurrent validity (compared with the CRS-R which has already been translated and validated in Mandarin), intra-rater reliability, and inter-rater reliability of the Chinese version of the SECONDs
Study Type
Interventional
Enrollment (Actual)
49
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China
- International Vegetative State and Consciousness Science Institute, Hangzhou Normal University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 83 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Acute (longer than 14 days, less than 28 days) or prolonged DoC (following severe acquired brain injury, longer than 28 days);
- Age: 18-85 years old;
- No history of other neurological or psychiatric deficits;
- Ability to speak Chinese fluently;
- Medical stability (e.g., absence of mechanical ventilation, sedation, infection)
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patients in coma
Patients in coma were assessed by the SECONDs and CRS-R for five days.
|
All patients were assessed by the Simplified Evaluation of CONsciousness Disorders (SECONDs) and Coma Recovery Scale-Revised (CRS-R)
|
Experimental: Patients in unresponsive wakefulness syndrome
Patients in unresponsive wakefulness syndrome were assessed by the SECONDs and CRS-R for five days.
|
All patients were assessed by the Simplified Evaluation of CONsciousness Disorders (SECONDs) and Coma Recovery Scale-Revised (CRS-R)
|
Experimental: Patients in minimally conscious state
Patients in minimally conscious state were assessed by the SECONDs and CRS-R for five days.
|
All patients were assessed by the Simplified Evaluation of CONsciousness Disorders (SECONDs) and Coma Recovery Scale-Revised (CRS-R)
|
Experimental: Patients in emerge from the minimally conscious state
Patients in emerge from the minimally conscious state were assessed by the SECONDs and CRS-R for five days.
|
All patients were assessed by the Simplified Evaluation of CONsciousness Disorders (SECONDs) and Coma Recovery Scale-Revised (CRS-R)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assess the reliability and validity of the Chinese version of the SECONDs
Time Frame: Within 10 days
|
The reliability and validity of the Chinese version of the SECONDs were evaluated by calculating the weighted Cohen's Kappa and Spearman coefficients of the differences between SECONDs and CRS-R in the diagnosis of MCS and UWS patients
|
Within 10 days
|
Diagnose the level of consciousness in patients through SECONDs and CRS-R
Time Frame: Within 10 days
|
Detect acute (longer than 14 days, less than 28 days) or prolonged DoC (following severe acquired brain injury, longer than 28 days) patients through Simplified Evaluation of CONsciousness Disorders (SECONDs).
|
Within 10 days
|
Diagnose the level of consciousness in patients through CRS-R
Time Frame: Within 10 days
|
Detect acute (longer than 14 days, less than 28 days) or prolonged DoC (following severe acquired brain injury, longer than 28 days) patients through Coma Recovery Scale-Revised (CRS-R).
|
Within 10 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Haibo Di, International Vegetative State and Consciousness Science Institute,Hangzhou Normal University
- Principal Investigator: Anqi Wang, International Vegetative State and Consciousness Science Institute,Hangzhou Normal University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 20, 2021
Primary Completion (Actual)
March 14, 2022
Study Completion (Actual)
March 14, 2022
Study Registration Dates
First Submitted
August 1, 2022
First Submitted That Met QC Criteria
August 9, 2022
First Posted (Actual)
August 11, 2022
Study Record Updates
Last Update Posted (Actual)
August 11, 2022
Last Update Submitted That Met QC Criteria
August 9, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- YCYY-20211021-003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Diseases
-
Brent MaselThe Moody FoundationCompletedChronic Traumatic Brain InjuryUnited States
-
Center for Vision Development, New Market, MarylandUnknownBrain Injuries | Brain Injuries, Traumatic | Traumatic Brain Injury | Brain Injury, Chronic | Injury, Brain, TraumaticUnited States
-
Toronto Rehabilitation InstituteCentre for Aging and Brain Health Innovation; Ontario Neurotrauma FoundationUnknownBrain Injuries, Traumatic | Brain Injury, Chronic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateCanada
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...Enrolling by invitationMild Traumatic Brain Injury | Concussion, BrainUnited States
-
Oculogica, Inc.CompletedMild Traumatic Brain Injury | Concussion, BrainUnited States
-
Oculogica, Inc.Completed
-
University of TurkuTurku University Hospital; The Finnish Funding Agency for Technology and Innovation... and other collaboratorsCompletedBrain Injuries | TBI (Traumatic Brain Injury) | Brain Injuries, Traumatic | Traumatic Brain Injury | Injury, Brain, TraumaticFinland
-
University of Sao Paulo General HospitalUnknownTraumatic Brain Injury | Severe Brain Injury | Closed Traumatic Brain InjuryBrazil
-
Virginia Commonwealth UniversityU.S. Department of EducationCompletedTraumatic Brain Injury | Brain Injury, ChronicUnited States
-
University of AarhusAarhus University Hospital; Central Denmark RegionCompletedTraumatic Brain INjuryDenmark
Clinical Trials on Simplified Evaluation of CONsciousness Disorders (SECONDs)
-
Hangzhou Normal UniversityCompleted
-
Centre Hospitalier St AnneCompletedPost-stroke DepressionFrance
-
Centre Hospitalier Universitaire de NīmesUniversity Hospital, Montpellier; M2H laboratory, Montpellier University; IMT... and other collaboratorsCompletedStroke | Brain Hypoxia | Traumatic Brain Injury With Prolonged Loss of ConsciousnessFrance
-
Medical University of GrazCompletedType 1 Diabetes MellitusAustria
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingPulmonary Langerhans Cell HistiocytosisFrance
-
University Hospital, MontpellierNot yet recruitingEating Disorders | Eating Disorder Binge
-
University Hospital, MontpellierINSERM 1061, " Neuropsychiatry: epidemiological and clinical research", MontpellierActive, not recruiting
-
Second Affiliated Hospital, School of Medicine,...RecruitingCarcinoma, HepatocellularChina
-
Daniela KandiolerMedical University of Vienna; Austrian Society Of Surgical OncologyCompletedEsophageal CancerAustria
-
Hospices Civils de LyonRecruitingNeurocognitive DisordersFrance